3D Systems (DDD) veröffentlicht Q2 2014 Ergebnisse – Update: Avi Reichental über Amazon und Aktien

3D Systems stellt die Zahlen für ihr zweites Quartal 2014 der Öffentlichkeit zur Verfügung.

Die Umsätze des 3D-Druck Riesen wuchsen auf 151,5 Millionen US $ und verfehlten die Erwartungen von Analysten und Aktienbesitzern. Die Reaktion auf den nur schwachen Anstieg der Einnahmen war ein Fall des Aktienwerts um 10% nach der Bekanntgabe und mittlerweile ein Fall um insgesamt rund 15%.

Highlights aus dem Q2 2014 Kauf von Medical Modeling, Übernahmen des latein-amerikanisches Unternehmens Robtec, Partnerschaften mit ScanSource und Konica Minolta U.S.A.

Die komplette Pressemeldung:

ROCK HILL, South Carolina – July 31, 2014 – 3D Systems Corporation (NYSE: DDD) announced today that its second quarter revenue grew $30.7 million, or 25%, from the prior year to $151.5 million on strong demand for its design and manufacturing printers, materials and services, resulting in second quarter GAAP earnings of $0.02 per share and non-GAAP earnings of $0.16 per share.

Organic growth amounted to 10% as additional orders-in-hand, including $23.1 million of printer orders, a 29% sequential increase over the March backlog for printers, expanded the company’s second quarter total backlog to a record $31.9 million.
“We are pleased that unit sales of our design and manufacturing printers increased 126% and helped fuel a 30% increase in materials revenue. We believe that the record order book that we exited the quarter with reflects the vibrancy of our business and our organic growth trajectory,” said Avi Reichental, 3DS’ President and Chief Executive Officer.

Second Quarter 2014 Revenue Highlights (compared to second quarter 2013):

• Design and manufacturing revenue increased 28% to $144.2 million on a 126% increase in units sold.
• Growing installed base and increased printer utilization fueled materials revenue growth of 30%.
• Expanding services menu contributed to a 38% increase in services revenue.
• Delayed new products availability held consumer revenue to $7.4 million, but didn’t impede higher consumer bookings of an additional $7.7 million.
• Healthcare revenue increased 46% to $27.5 million from expanding services and capabilities.

Gross profit margin shouldered the transitional effects of concentrated new product launches as well as the absorption of legacy products obsolescence and manufacturing expansion costs. Together, these factors and changed mix compressed gross profit margin some 400 basis points from the prior year’s quarter to 47.8%.

“While transitional forces temporarily pressured our gross profit margin, a detailed examination of the specific drivers, confirms that the fundamentals of our business are intact and our gross profit margins are poised to rebound and resume their expansion trajectory,” continued Reichental.

The company effectively kept its operating expenses flat, on a sequential basis, even with continued investments in R&D, sales, marketing and manufacturing capacity. The company generated $19.0 million of cash from operations during the second quarter as returns on its recent investments began to materialize and enterprise-wide integration synergies continued to accrue. The company ended the quarter with $570.3 million cash on hand, inclusive of an equity raise completed earlier in the quarter.

“As we advance our market leadership and scale in key verticals through our increased investments, our progress is ahead of schedule and our enterprise-wide synergies are already generating substantial cash from operations,” continued Reichental.

For the six months 2014, revenue grew $76.4 million, or 34%, with growth distributed broadly across all categories, to $299.3 million, resulting in GAAP earnings per share of $0.07 per share and non-GAAP earnings per share of $0.30 per share.

Recent Business Highlights

• The company acquired Medical Modeling, a leading provider of FDA cleared, personalized surgical treatment planning and patient specific medical devices, to create the most comprehensive 3D printing medical device capabilities and enhance its 3D printing digital thread.
• The company signed a definitive agreement to acquire Robtec, which will provide a strategic sales and service platform and scalable gateway into Latin America.
• The company extended its global reseller channel, adding several key distributors including ScanSource, Konica Minolta and Cannon Marketing Japan.
• The company signed a definitive agreement to acquire Simbionix, the global leader in 3D virtual reality surgical simulation, to extend its healthcare reach from the training room to the operating room with the addition of powerful synergistic technology, deep experience and domain expertise.

3DS entered the second half of this year with a substantially larger order book and favorable growth indicators. The company typically realizes a higher portion of its annual revenue during the second half of the year, and expects the same in the remainder of 2014 as the full impact of its new products and services and recent investments materializes. Factoring in the expected net contribution after closure of the Simbionix acquisition and delayed closing of the Robtec acquisition that was already included in its previous guidance, management raised its 2014 revenue guidance. Management expects revenue to be in the range of $700 million to $740 million and its GAAP earnings per share to be in the range of $0.44 to $0.56 and non-GAAP earnings per share to be in the range of $0.73 to $0.85.

“Consistent with our historical performance, we expect to generate a higher portion of our revenue during the second half on rebounding margins. Record bookings for our design and manufacturing printers together with rising orders for our consumer products provides us with confidence in our ability to achieve our 2014 guidance,” concluded Reichental.

06.08.2014 Update: Avi Reichental wird über FOX News interviewed

Fox News interviewte 3D Systems CEO, Avi Reichental zu dem Start von Amazons 3D-Druck Service und den Fall der 3D Systems (DDD) Aktien. Auch die Partnerschaft von Shapewasys und Hasbros My Little Pony wird von Avi Reichental erläutert.

via 3D Systems